TICAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ticar, and what generic alternatives are available?
Ticar is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TICAR?
- What are the global sales for TICAR?
- What is Average Wholesale Price for TICAR?
Summary for TICAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Patent Applications: | 1,605 |
| DailyMed Link: | TICAR at DailyMed |
US Patents and Regulatory Information for TICAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 062690-001 | Dec 19, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | TICAR | ticarcillin disodium | INJECTABLE;INJECTION | 050497-005 | Apr 4, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
